Cyclosporine or Tacrolimus: Which Is the Better Partner for Myfortic or CellCept?
Authors:
- S.-S. ChangSCS.-S. Chang
- S.-C. ShiehSSS.-C. Shieh
- Z.-C. WuZWZ.-C. Wu
- W.-M. WangWWW.-M. Wang
- J.-D. WangJWJ.-D. Wang
- C.-J. HungCHC.-J. Hung
- Y.-J. LinYLY.-J. Lin
- T.-C. ChouTCT.-C. Chou
- R.-H. ChanRCR.-H. Chan
- 29 February 2012
- journal article
- research article
- Published by Elsevier in Transplantation Proceedings
- Vol. 44 (1) , 137-139
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- The pharmacokinetics of mycophenolate mofetil in renal transplant recipients receiving standard-dose or low-dose cyclosporine, low-dose tacrolimus or low-dose sirolimus: the Symphony pharmacokinetic substudyNephrology Dialysis Transplantation, 2009
- Reduced Exposure to Calcineurin Inhibitors in Renal TransplantationNew England Journal of Medicine, 2008
- Mycophenolate mofetil reduces deterioration of renal function in patients with chronic allograft nephropathyTransplantation, 2004
- The influence of calcineurin inhibitors on mycophenolic acid pharmacokineticsTransplantation Proceedings, 2003
- All chronic rejection failures of kidney transplants were preceded by the development of HLA antibodiesTransplantation, 2002
- A RANDOMIZED DOUBLE-BLIND, MULTICENTER PLASMA CONCENTRATION CONTROLLED STUDY OF THE SAFETY AND EFFICACY OF ORAL MYCOPHENOLATE MOFETIL FOR THE PREVENTION OF ACUTE REJECTION AFTER KIDNEY TRANSPLANTATION1Transplantation, 1999
- Unexpected augmentation of mycophenolic acid pharmacokinetics in renal transplant patients receiving tacrolimus and mycophenolate mofetil in combination therapy, and analogous in vitro findingsTransplant Immunology, 1997